Skip to main content
Book cover

Neuroacanthocytosis Syndromes II

  • Book
  • © 2008

Overview

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (24 chapters)

  1. The Neuroacanthocytosis Syndromes

  2. Basic Research - Proteins and Erythrocytes

  3. Animal Models

  4. The Structural Basis of Brain Involvement in Neuroacanthocytosis

  5. Clinical Aspects and Therapy

Keywords

About this book

Neuroacanthocytosis refers to a group of rare neurodegenerative disorders, the symptoms of which typically resemble Huntington’s disease. One defining feature is the presence of thorny red blood cells (acanthocytes); however, neither the role of the genetic mutations in causing acanthocytosis, nor the connection with the basal ganglia neurodegeneration, is yet understood. At present there is no cure for these disorders and treatment is purely symptomatic.

Awareness of neuroacanthocytosis disorders has increased significantly in recent years. There have been a number of important developments in the field since the publication of the first volume, Neuroacanthocytosis Syndromes. This book contains the latest research in this area.

Recent advances have identified the range of mutations in the causative genes, shedding light on potential phenotype­genotype correlations. Studies of the proteins affected in these disorders have resulted in increased understanding of their functions and distribution. In vitro studies have identified potential protein interactions, which have important implications for pathophysiology. Work on erythrocyte membranes suggests mechanisms for the generation of acanthocytes. Animal models are being generated which will greatly facilitate understanding the role of gene mutations in humans, and provide the foundation for possible therapeutic interventions. In addition, advances in other neurodegenerative disorders, such as Huntington’s and Parkinson’s diseases, have implications for neuroacanthocytosis.

 

Editors and Affiliations

  • Movement Disorders Clinic Department of Neurology, James J. Peters Veterans Affairs Medical Center, Bronx

    Ruth H. Walker

  • Department of Neurology, Mount Sinai School of Medicine, New York, USA

    Ruth H. Walker

  • Department of Medical Genetics Cambridge Institute for Medical Research Wellcome Trust/MRC Building, Addenbrooke’s Hospital, Cambridge, UK

    Shinji Saiki

  • Neurologische Klinik, Ludwig-Maximilians-Universität, München, Germany

    Adrian Danek

Bibliographic Information

  • Book Title: Neuroacanthocytosis Syndromes II

  • Editors: Ruth H. Walker, Shinji Saiki, Adrian Danek

  • DOI: https://doi.org/10.1007/978-3-540-71693-8

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2008

  • Hardcover ISBN: 978-3-540-71692-1Published: 18 December 2007

  • Softcover ISBN: 978-3-642-09082-0Published: 15 October 2010

  • eBook ISBN: 978-3-540-71693-8Published: 22 December 2007

  • Edition Number: 1

  • Number of Pages: XXVI, 295

  • Topics: Neurosciences, Neurology, Human Genetics

Publish with us